On-demand: Overcoming financial toxicity in oncology clinical trials

Originally published on the Greenphire website prior to the merger with Suvoda in 2025.

Less than 5% of adult patients with cancer participate in clinical trials.

Despite the promise of improved care and cutting-edge treatments, high costs and financial burden of oncology clinical trials often turn eligible participants away.

However, we invite you to make a change!

During this Trailblazer Webinar, you’ll hear how groups like American Cancer Society Action Network and LUNGevity are forging a new path towards improved patient experience and stronger study outcomes.

You’ll hear:

• Why financial toxicity has historically plagued oncology research
• What the industry can do to remove these impediments, and also
• Important advocacy work being conducted right now in Washington, DC to reduce the tax impact of patient stipends
  
  

Watch Now

Please note: You must register first to watch the replay. After registering, you will receive a link to access the recorded event.